📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Lyka Labs Amalgamation Update: NCLT Reserves Order Following FEMA Compliance Review
Lyka Labs Limited has provided a regulatory update regarding its ongoing Scheme of Amalgamation. The National Company Law Tribunal (NCLT) has reviewed the company's submissions and affidavits concerning FEMA compliance and Import Export Code guidelines. Following these submissions, the NCLT has officially reserved its order on the matter. This indicates that the judicial hearing phase is complete, and a final decision on the merger is expected shortly.
Key Highlights
NCLT has reserved the final order regarding the Scheme of Amalgamation for Lyka Labs.
Company submitted compliance affidavits related to FEMA guidelines and Import Export Code as directed.
The update follows a previous regulatory intimation dated February 2, 2026.
The tribunal's jurisdiction covers both the Transferor and Transferee companies involved in the deal.
💼 Action for Investors
Investors should await the final NCLT order as it will determine the legal completion of the merger. Monitor the stock for price sensitivity once the final judgment is made public.
Lyka Labs Amalgamation Update: NCLT Hearing Scheduled for February 19, 2026
Lyka Labs Limited has provided a procedural update regarding its ongoing Scheme of Amalgamation before the NCLT Ahmedabad Bench. During the hearing on January 29, 2026, the company confirmed it has complied with all previous tribunal orders. The NCLT is currently examining an affidavit filed by the company specifically regarding FEMA compliance. The matter has now been listed for a subsequent hearing on February 19, 2026.
Key Highlights
NCLT Ahmedabad Bench reviewed the amalgamation application on January 29, 2026
Company confirmed compliance with all previous orders passed by the Hon’ble Tribunal
Tribunal is currently examining a specific affidavit regarding FEMA compliance
Next hearing for the amalgamation scheme is scheduled for February 19, 2026
💼 Action for Investors
Investors should track the outcome of the February 19 hearing as the amalgamation is a significant corporate restructuring event. Maintain a watch on the stock for any volatility leading up to the final NCLT approval.
Lyka Labs Q3 Results: Standalone Profit Jumps to ₹2.7 Cr; Consolidated Swings to Loss
Lyka Labs reported a mixed performance for the quarter ended December 31, 2025. On a standalone basis, the company saw a significant jump in net profit to ₹269.85 lakhs from ₹26.14 lakhs in the previous year. However, the consolidated results show a net loss of ₹15.12 lakhs compared to a profit of ₹270.40 lakhs in Q3 FY25, driven by a 9% decline in consolidated revenue. The company also accounted for a one-time impact of ₹11.41 lakhs related to new Labour Code regulations.
Key Highlights
Standalone Net Profit surged to ₹269.85 lakhs from ₹26.14 lakhs YoY.
Consolidated Revenue from operations fell to ₹3,072.80 lakhs from ₹3,379.76 lakhs YoY.
Consolidated bottom line swung to a loss of ₹15.12 lakhs from a profit of ₹270.40 lakhs in the year-ago period.
Company paid a premium of ₹217.14 lakhs on the redemption of 1,08,570 preference shares, adjusted against General Reserve.
Recognized a one-time incremental impact of ₹11.41 lakhs under Employee Benefit Expenses due to new Labour Codes.
💼 Action for Investors
Investors should exercise caution as the consolidated performance indicates significant weakness in subsidiaries, leading to an overall group loss despite standalone growth. Monitor the company's ability to stabilize consolidated margins in the upcoming quarters.
Lyka Labs Amalgamation Order Delayed; NCLT Sets Next Hearing for January 29, 2026
Lyka Labs has provided an update regarding its Scheme of Amalgamation currently under review by the NCLT Ahmedabad Bench. While the order was previously reserved on December 5, 2025, the tribunal called for further clarifications on December 18, 2025. Consequently, the matter has now been scheduled for further consideration on January 29, 2026. This delay extends the timeline for the completion of the merger process for both the Transferor and Transferee companies.
Key Highlights
NCLT Ahmedabad Bench had previously reserved the order on December 5, 2025.
The matter was listed for further clarification on December 18, 2025.
The next hearing for further consideration is scheduled for January 29, 2026.
The amalgamation involves both the Transferor and Transferee companies under the same jurisdiction.
💼 Action for Investors
Investors should monitor the outcome of the January 29 hearing as it will determine the progress of the merger. The delay may cause short-term price volatility due to extended uncertainty.
LYKALABS: NCLT reserves order on Scheme of Amalgamation
Lyka Labs Limited announced that the Hon’ble National Company Law Tribunal (NCLT), Ahmedabad Bench, has reserved its order regarding the Scheme of Amalgamation. This follows an earlier update on November 8th, 2025, and a last opportunity granted to the Income Tax counsel to file a reply. The Income Tax Department's counsel has stated no objection to the merger application. The company received a copy of the NCLT order on December 5th, 2025.
Key Highlights
NCLT Ahmedabad Bench reserved its order on the Scheme of Amalgamation.
Income Tax Department's counsel has no objection to the merger application.
Company received NCLT order copy on December 5th, 2025.
💼 Action for Investors
Investors should monitor further announcements from the company regarding the NCLT order. Review the company's website for more information on the amalgamation scheme.